Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view Article Swipe
Ali Najmeddin
,
Mina Bahrololoumi Shapourabadi
,
Mahdi Behdani
,
Farid Abedin Dorkoosh
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1016/j.bbagen.2021.129974
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1016/j.bbagen.2021.129974
Related Topics
Concepts
Coronavirus disease 2019 (COVID-19)
Medicine
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2019-20 coronavirus outbreak
Intensive care medicine
Disease
Infectious disease (medical specialty)
Virology
Pathology
Outbreak
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.bbagen.2021.129974
- OA Status
- green
- Cited By
- 15
- References
- 90
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3191811381
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3191811381Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.bbagen.2021.129974Digital Object Identifier
- Title
-
Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of viewWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-07-31Full publication date if available
- Authors
-
Ali Najmeddin, Mina Bahrololoumi Shapourabadi, Mahdi Behdani, Farid Abedin DorkooshList of authors in order
- Landing page
-
https://doi.org/10.1016/j.bbagen.2021.129974Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/8325376Direct OA link when available
- Concepts
-
Coronavirus disease 2019 (COVID-19), Medicine, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 2019-20 coronavirus outbreak, Intensive care medicine, Disease, Infectious disease (medical specialty), Virology, Pathology, OutbreakTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
15Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 3, 2023: 7, 2022: 4, 2021: 1Per-year citation counts (last 5 years)
- References (count)
-
90Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3191811381 |
|---|---|
| doi | https://doi.org/10.1016/j.bbagen.2021.129974 |
| ids.doi | https://doi.org/10.1016/j.bbagen.2021.129974 |
| ids.mag | 3191811381 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/34343644 |
| ids.openalex | https://openalex.org/W3191811381 |
| fwci | 1.09715552 |
| mesh[0].qualifier_ui | Q000037 |
| mesh[0].descriptor_ui | D000085962 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | antagonists & inhibitors |
| mesh[0].descriptor_name | Angiotensin-Converting Enzyme 2 |
| mesh[1].qualifier_ui | Q000235 |
| mesh[1].descriptor_ui | D000085962 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | genetics |
| mesh[1].descriptor_name | Angiotensin-Converting Enzyme 2 |
| mesh[2].qualifier_ui | Q000276 |
| mesh[2].descriptor_ui | D000085962 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | immunology |
| mesh[2].descriptor_name | Angiotensin-Converting Enzyme 2 |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000818 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Animals |
| mesh[4].qualifier_ui | Q000096 |
| mesh[4].descriptor_ui | D057134 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | biosynthesis |
| mesh[4].descriptor_name | Antibodies, Neutralizing |
| mesh[5].qualifier_ui | Q000302 |
| mesh[5].descriptor_ui | D057134 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | isolation & purification |
| mesh[5].descriptor_name | Antibodies, Neutralizing |
| mesh[6].qualifier_ui | Q000627 |
| mesh[6].descriptor_ui | D057134 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | therapeutic use |
| mesh[6].descriptor_name | Antibodies, Neutralizing |
| mesh[7].qualifier_ui | Q000302 |
| mesh[7].descriptor_ui | D000998 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | isolation & purification |
| mesh[7].descriptor_name | Antiviral Agents |
| mesh[8].qualifier_ui | Q000378 |
| mesh[8].descriptor_ui | D000998 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | metabolism |
| mesh[8].descriptor_name | Antiviral Agents |
| mesh[9].qualifier_ui | Q000627 |
| mesh[9].descriptor_ui | D000998 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | therapeutic use |
| mesh[9].descriptor_name | Antiviral Agents |
| mesh[10].qualifier_ui | Q000276 |
| mesh[10].descriptor_ui | D000086382 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | immunology |
| mesh[10].descriptor_name | COVID-19 |
| mesh[11].qualifier_ui | Q000628 |
| mesh[11].descriptor_ui | D000086382 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | therapy |
| mesh[11].descriptor_name | COVID-19 |
| mesh[12].qualifier_ui | Q000821 |
| mesh[12].descriptor_ui | D000086382 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | virology |
| mesh[12].descriptor_name | COVID-19 |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D002162 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Camelus |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D016503 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Drug Delivery Systems |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D006801 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Humans |
| mesh[16].qualifier_ui | Q000737 |
| mesh[16].descriptor_ui | D007106 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | chemistry |
| mesh[16].descriptor_name | Immune Sera |
| mesh[17].qualifier_ui | Q000096 |
| mesh[17].descriptor_ui | D007155 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | biosynthesis |
| mesh[17].descriptor_name | Immunologic Factors |
| mesh[18].qualifier_ui | Q000302 |
| mesh[18].descriptor_ui | D007155 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | isolation & purification |
| mesh[18].descriptor_name | Immunologic Factors |
| mesh[19].qualifier_ui | Q000627 |
| mesh[19].descriptor_ui | D007155 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | therapeutic use |
| mesh[19].descriptor_name | Immunologic Factors |
| mesh[20].qualifier_ui | Q000187 |
| mesh[20].descriptor_ui | D008168 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | drug effects |
| mesh[20].descriptor_name | Lung |
| mesh[21].qualifier_ui | Q000276 |
| mesh[21].descriptor_ui | D008168 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | immunology |
| mesh[21].descriptor_name | Lung |
| mesh[22].qualifier_ui | Q000821 |
| mesh[22].descriptor_ui | D008168 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | virology |
| mesh[22].descriptor_name | Lung |
| mesh[23].qualifier_ui | Q000379 |
| mesh[23].descriptor_ui | D058990 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | methods |
| mesh[23].descriptor_name | Molecular Targeted Therapy |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D019151 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Peptide Library |
| mesh[25].qualifier_ui | Q000187 |
| mesh[25].descriptor_ui | D011485 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | drug effects |
| mesh[25].descriptor_name | Protein Binding |
| mesh[26].qualifier_ui | Q000187 |
| mesh[26].descriptor_ui | D000086402 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | drug effects |
| mesh[26].descriptor_name | SARS-CoV-2 |
| mesh[27].qualifier_ui | Q000235 |
| mesh[27].descriptor_ui | D000086402 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | genetics |
| mesh[27].descriptor_name | SARS-CoV-2 |
| mesh[28].qualifier_ui | Q000276 |
| mesh[28].descriptor_ui | D000086402 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | immunology |
| mesh[28].descriptor_name | SARS-CoV-2 |
| mesh[29].qualifier_ui | Q000096 |
| mesh[29].descriptor_ui | D061905 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | biosynthesis |
| mesh[29].descriptor_name | Single-Domain Antibodies |
| mesh[30].qualifier_ui | Q000302 |
| mesh[30].descriptor_ui | D061905 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | isolation & purification |
| mesh[30].descriptor_name | Single-Domain Antibodies |
| mesh[31].qualifier_ui | Q000627 |
| mesh[31].descriptor_ui | D061905 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | therapeutic use |
| mesh[31].descriptor_name | Single-Domain Antibodies |
| mesh[32].qualifier_ui | Q000037 |
| mesh[32].descriptor_ui | D064370 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | antagonists & inhibitors |
| mesh[32].descriptor_name | Spike Glycoprotein, Coronavirus |
| mesh[33].qualifier_ui | Q000235 |
| mesh[33].descriptor_ui | D064370 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | genetics |
| mesh[33].descriptor_name | Spike Glycoprotein, Coronavirus |
| mesh[34].qualifier_ui | Q000276 |
| mesh[34].descriptor_ui | D064370 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | immunology |
| mesh[34].descriptor_name | Spike Glycoprotein, Coronavirus |
| mesh[35].qualifier_ui | Q000037 |
| mesh[35].descriptor_ui | D000085962 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | antagonists & inhibitors |
| mesh[35].descriptor_name | Angiotensin-Converting Enzyme 2 |
| mesh[36].qualifier_ui | Q000235 |
| mesh[36].descriptor_ui | D000085962 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | genetics |
| mesh[36].descriptor_name | Angiotensin-Converting Enzyme 2 |
| mesh[37].qualifier_ui | Q000276 |
| mesh[37].descriptor_ui | D000085962 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | immunology |
| mesh[37].descriptor_name | Angiotensin-Converting Enzyme 2 |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D000818 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Animals |
| mesh[39].qualifier_ui | Q000096 |
| mesh[39].descriptor_ui | D057134 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | biosynthesis |
| mesh[39].descriptor_name | Antibodies, Neutralizing |
| mesh[40].qualifier_ui | Q000302 |
| mesh[40].descriptor_ui | D057134 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | isolation & purification |
| mesh[40].descriptor_name | Antibodies, Neutralizing |
| mesh[41].qualifier_ui | Q000627 |
| mesh[41].descriptor_ui | D057134 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | therapeutic use |
| mesh[41].descriptor_name | Antibodies, Neutralizing |
| mesh[42].qualifier_ui | Q000302 |
| mesh[42].descriptor_ui | D000998 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | isolation & purification |
| mesh[42].descriptor_name | Antiviral Agents |
| mesh[43].qualifier_ui | Q000378 |
| mesh[43].descriptor_ui | D000998 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | metabolism |
| mesh[43].descriptor_name | Antiviral Agents |
| mesh[44].qualifier_ui | Q000627 |
| mesh[44].descriptor_ui | D000998 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | therapeutic use |
| mesh[44].descriptor_name | Antiviral Agents |
| mesh[45].qualifier_ui | Q000276 |
| mesh[45].descriptor_ui | D000086382 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | immunology |
| mesh[45].descriptor_name | COVID-19 |
| mesh[46].qualifier_ui | Q000628 |
| mesh[46].descriptor_ui | D000086382 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | therapy |
| mesh[46].descriptor_name | COVID-19 |
| mesh[47].qualifier_ui | Q000821 |
| mesh[47].descriptor_ui | D000086382 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | virology |
| mesh[47].descriptor_name | COVID-19 |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D002162 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Camelus |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D016503 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Drug Delivery Systems |
| type | review |
| title | Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view |
| biblio.issue | 11 |
| biblio.volume | 1865 |
| biblio.last_page | 129974 |
| biblio.first_page | 129974 |
| grants[0].funder | https://openalex.org/F4320322670 |
| grants[0].award_id | |
| grants[0].funder_display_name | Tehran University of Medical Sciences and Health Services |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.998199999332428 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T11016 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9977999925613403 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2741 |
| topics[1].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[1].display_name | Monoclonal and Polyclonal Antibodies Research |
| topics[2].id | https://openalex.org/T10580 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9850000143051147 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immunotherapy and Immune Responses |
| funders[0].id | https://openalex.org/F4320322670 |
| funders[0].ror | https://ror.org/01c4pz451 |
| funders[0].display_name | Tehran University of Medical Sciences and Health Services |
| is_xpac | False |
| apc_list.value | 3450 |
| apc_list.currency | USD |
| apc_list.value_usd | 3450 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C3008058167 |
| concepts[0].level | 4 |
| concepts[0].score | 0.7063894271850586 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[0].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6133959889411926 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C3007834351 |
| concepts[2].level | 5 |
| concepts[2].score | 0.5859922170639038 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[2].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[3].id | https://openalex.org/C3006700255 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5051689743995667 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q81068910 |
| concepts[3].display_name | 2019-20 coronavirus outbreak |
| concepts[4].id | https://openalex.org/C177713679 |
| concepts[4].level | 1 |
| concepts[4].score | 0.46762615442276 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[4].display_name | Intensive care medicine |
| concepts[5].id | https://openalex.org/C2779134260 |
| concepts[5].level | 2 |
| concepts[5].score | 0.37701526284217834 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[5].display_name | Disease |
| concepts[6].id | https://openalex.org/C524204448 |
| concepts[6].level | 3 |
| concepts[6].score | 0.3516138792037964 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[6].display_name | Infectious disease (medical specialty) |
| concepts[7].id | https://openalex.org/C159047783 |
| concepts[7].level | 1 |
| concepts[7].score | 0.3202275037765503 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[7].display_name | Virology |
| concepts[8].id | https://openalex.org/C142724271 |
| concepts[8].level | 1 |
| concepts[8].score | 0.08930835127830505 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[8].display_name | Pathology |
| concepts[9].id | https://openalex.org/C116675565 |
| concepts[9].level | 2 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q3241045 |
| concepts[9].display_name | Outbreak |
| keywords[0].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[0].score | 0.7063894271850586 |
| keywords[0].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.6133959889411926 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[2].score | 0.5859922170639038 |
| keywords[2].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[3].id | https://openalex.org/keywords/2019-20-coronavirus-outbreak |
| keywords[3].score | 0.5051689743995667 |
| keywords[3].display_name | 2019-20 coronavirus outbreak |
| keywords[4].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[4].score | 0.46762615442276 |
| keywords[4].display_name | Intensive care medicine |
| keywords[5].id | https://openalex.org/keywords/disease |
| keywords[5].score | 0.37701526284217834 |
| keywords[5].display_name | Disease |
| keywords[6].id | https://openalex.org/keywords/infectious-disease |
| keywords[6].score | 0.3516138792037964 |
| keywords[6].display_name | Infectious disease (medical specialty) |
| keywords[7].id | https://openalex.org/keywords/virology |
| keywords[7].score | 0.3202275037765503 |
| keywords[7].display_name | Virology |
| keywords[8].id | https://openalex.org/keywords/pathology |
| keywords[8].score | 0.08930835127830505 |
| keywords[8].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1016/j.bbagen.2021.129974 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S4210238601 |
| locations[0].source.issn | 0304-4165, 1872-8006 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0304-4165 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Biochimica et Biophysica Acta (BBA) - General Subjects |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Biochimica et Biophysica Acta (BBA) - General Subjects |
| locations[0].landing_page_url | https://doi.org/10.1016/j.bbagen.2021.129974 |
| locations[1].id | pmid:34343644 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Biochimica et biophysica acta. General subjects |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/34343644 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:8325376 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Biochim Biophys Acta Gen Subj |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8325376 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5022614366 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-8408-0519 |
| authorships[0].author.display_name | Ali Najmeddin |
| authorships[0].countries | IR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I70640408 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pharmaceutics, Faculty of pharmacy, Tehran University of Medical Sciences, Iran |
| authorships[0].institutions[0].id | https://openalex.org/I70640408 |
| authorships[0].institutions[0].ror | https://ror.org/01c4pz451 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I70640408 |
| authorships[0].institutions[0].country_code | IR |
| authorships[0].institutions[0].display_name | Tehran University of Medical Sciences |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ali Najmeddin |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pharmaceutics, Faculty of pharmacy, Tehran University of Medical Sciences, Iran |
| authorships[1].author.id | https://openalex.org/A5047520096 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Mina Bahrololoumi Shapourabadi |
| authorships[1].affiliations[0].raw_affiliation_string | HUM Immune Biotechnology Institute, Tehran, Iran |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mina Bahrololoumi Shapourabadi |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | HUM Immune Biotechnology Institute, Tehran, Iran |
| authorships[2].author.id | https://openalex.org/A5076080250 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-4839-5123 |
| authorships[2].author.display_name | Mahdi Behdani |
| authorships[2].countries | IR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1301411061 |
| authorships[2].affiliations[0].raw_affiliation_string | Venom and Biotherapeutic Molecules Lab, Biotechnology Research Centre, Pasteur Institute of Iran, Tehran, Iran |
| authorships[2].institutions[0].id | https://openalex.org/I1301411061 |
| authorships[2].institutions[0].ror | https://ror.org/00wqczk30 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I1301411061 |
| authorships[2].institutions[0].country_code | IR |
| authorships[2].institutions[0].display_name | Pasteur Institute of Iran |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Mahdi Behdani |
| authorships[2].is_corresponding | True |
| authorships[2].raw_affiliation_strings | Venom and Biotherapeutic Molecules Lab, Biotechnology Research Centre, Pasteur Institute of Iran, Tehran, Iran |
| authorships[3].author.id | https://openalex.org/A5088557823 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-0417-7300 |
| authorships[3].author.display_name | Farid Abedin Dorkoosh |
| authorships[3].countries | IR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I70640408 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pharmaceutics, Faculty of pharmacy, Tehran University of Medical Sciences, Iran |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I70640408 |
| authorships[3].affiliations[1].raw_affiliation_string | Medical Biomaterial Research Center (MBRC), Tehran University of Medical Sciences, Iran |
| authorships[3].institutions[0].id | https://openalex.org/I70640408 |
| authorships[3].institutions[0].ror | https://ror.org/01c4pz451 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I70640408 |
| authorships[3].institutions[0].country_code | IR |
| authorships[3].institutions[0].display_name | Tehran University of Medical Sciences |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Farid Dorkoosh |
| authorships[3].is_corresponding | True |
| authorships[3].raw_affiliation_strings | Department of Pharmaceutics, Faculty of pharmacy, Tehran University of Medical Sciences, Iran, Medical Biomaterial Research Center (MBRC), Tehran University of Medical Sciences, Iran |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8325376 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.998199999332428 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W4206669628, https://openalex.org/W3036314732, https://openalex.org/W4205317059, https://openalex.org/W3009669391, https://openalex.org/W4382894326, https://openalex.org/W3198183218, https://openalex.org/W3081785542, https://openalex.org/W3171943759, https://openalex.org/W3176864053, https://openalex.org/W3084498529 |
| cited_by_count | 15 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 7 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 4 |
| counts_by_year[3].year | 2021 |
| counts_by_year[3].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:8325376 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Biochim Biophys Acta Gen Subj |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8325376 |
| primary_location.id | doi:10.1016/j.bbagen.2021.129974 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S4210238601 |
| primary_location.source.issn | 0304-4165, 1872-8006 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0304-4165 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Biochimica et Biophysica Acta (BBA) - General Subjects |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Biochimica et Biophysica Acta (BBA) - General Subjects |
| primary_location.landing_page_url | https://doi.org/10.1016/j.bbagen.2021.129974 |
| publication_date | 2021-07-31 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W3108500958, https://openalex.org/W3119147846, https://openalex.org/W3024079853, https://openalex.org/W3133390774, https://openalex.org/W3009912996, https://openalex.org/W3024262723, https://openalex.org/W3119663014, https://openalex.org/W3113325024, https://openalex.org/W3046724041, https://openalex.org/W6778757637, https://openalex.org/W3091795902, https://openalex.org/W3090108357, https://openalex.org/W3133812656, https://openalex.org/W3110551733, https://openalex.org/W3035163373, https://openalex.org/W3116103971, https://openalex.org/W3012764845, https://openalex.org/W3041222256, https://openalex.org/W6778102822, https://openalex.org/W3082732146, https://openalex.org/W6777684647, https://openalex.org/W2983988502, https://openalex.org/W2169610187, https://openalex.org/W2765220198, https://openalex.org/W2949064374, https://openalex.org/W2905235833, https://openalex.org/W2018426009, https://openalex.org/W2112782031, https://openalex.org/W1978075036, https://openalex.org/W2965278931, https://openalex.org/W2095165830, https://openalex.org/W2018666104, https://openalex.org/W2905174690, https://openalex.org/W1969341069, https://openalex.org/W2190300929, https://openalex.org/W2159725619, https://openalex.org/W2915219798, https://openalex.org/W2810214460, https://openalex.org/W3095441755, https://openalex.org/W3007643904, https://openalex.org/W3146460310, https://openalex.org/W6791577964, https://openalex.org/W3037693577, https://openalex.org/W3115538028, https://openalex.org/W3133616244, https://openalex.org/W3134650514, https://openalex.org/W6785557659, https://openalex.org/W3164436793, https://openalex.org/W3096751000, https://openalex.org/W6791371870, https://openalex.org/W3128794919, https://openalex.org/W3093565226, https://openalex.org/W6790093295, https://openalex.org/W3095224136, https://openalex.org/W3096284144, https://openalex.org/W1946908482, https://openalex.org/W1978489475, https://openalex.org/W3048515223, https://openalex.org/W2991070374, https://openalex.org/W3081537465, https://openalex.org/W3013867929, https://openalex.org/W1486556378, https://openalex.org/W3134466246, https://openalex.org/W2996720940, https://openalex.org/W3036899627, https://openalex.org/W2465525754, https://openalex.org/W3187360417, https://openalex.org/W2903752946, https://openalex.org/W3126613859, https://openalex.org/W2770141606, https://openalex.org/W3138071441, https://openalex.org/W4226151758, https://openalex.org/W3023693498, https://openalex.org/W3011660632, https://openalex.org/W3037087735, https://openalex.org/W3098555035, https://openalex.org/W3029903184, https://openalex.org/W2914723465, https://openalex.org/W3003965112, https://openalex.org/W3098400443, https://openalex.org/W3201703011, https://openalex.org/W3102241621, https://openalex.org/W3210522317, https://openalex.org/W3134605973, https://openalex.org/W3000834598, https://openalex.org/W3166262177, https://openalex.org/W3133578840, https://openalex.org/W3080622028, https://openalex.org/W3048783206, https://openalex.org/W3025991930 |
| referenced_works_count | 90 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5076080250, https://openalex.org/A5088557823 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| corresponding_institution_ids | https://openalex.org/I1301411061, https://openalex.org/I70640408 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7900000214576721 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.79651253 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |